key: cord-0269326-xca1qznk
authors: Liu, Hongwei; Plancarte, Magdalena; Ball, Erin. E.; Weiss, Christopher M.; Gonzales-Viera, Omar; Holcomb, Karen; Ma, Zhong-Min; Allen, A. Mark; Reader, J. Rachel; Duignan, Pádraig J.; Halaska, Barbie; Khan, Zenab; Kriti, Divya; Dutta, Jayeeta; van Bakel, Harm; Jackson, Kenneth; Pesavento, Patricia A.; Boyce, Walter M.; Coffey, Lark L.
title: Respiratory tract explant infection dynamics of influenza A virus in California sea lions, northern elephant seals, and rhesus macaques and severe acute respiratory syndrome virus-2 in rhesus macaques
date: 2020-10-16
journal: bioRxiv
DOI: 10.1101/2020.10.15.342055
sha: f1ca01435686a7acc1a0750da42364e393b30954
doc_id: 269326
cord_uid: xca1qznk

To understand susceptibility of California sea lions and Northern elephant seals to influenza A virus (IAV), we developed an ex vivo respiratory explant model and used it to compare infection kinetics for multiple IAV subtypes. We used a similar approach with explants from rhesus macaques to establish the system and to compare infection kinetics with marine mammals. Trachea, bronchi, and lungs from 11 California sea lions, 2 Northern elephant seals and 10 rhesus macaques were inoculated within 24 hours post-mortem with 6 strains representing 4 IAV subtypes. Explants from all 3 species showed similar IAV infection kinetics with peak viral titers 48-72 hours post-inoculation (hpi) that increased by 2-4 log10 PFU/explant relative to the inoculum. Immunohistochemistry localized IAV infection to apical epithelial cells. These results demonstrate that respiratory tissue explants from marine mammals support IAV infection. In the absence of the ability to perform experimental infections of marine mammals, this ex vivo culture of respiratory tissues mirrors the in vivo environment and serves as a tool to study IAV susceptibility, host-range, and tissue tropism. We adapted the explant approach and used it to inoculate tissues from 2 rhesus macaques with severe acute respiratory syndrome virus 2 (SARS-CoV-2). SARS-CoV-2 titers increased by 2-4 log10 PFU/explant relative to the inoculum and peaked 48 or 72 hpi in trachea, bronchi, and kidney of both macaques and in the lung of 1 animal. These results demonstrate that this ex vivo model can define infection dynamics for 2 respiratory viruses of significant public health importance. Importance Although influenza A virus can infect marine mammals, a dearth of marine mammal cell lines and ethical and logistical challenges prohibiting experimental infections of living marine mammals means that little is known about IAV infection kinetics in these species. We circumvented these limitations by adapting a respiratory tract explant model first to establish the approach with rhesus macaques and then for use with marine mammals. We observed that multiple strains representing 4 IAV subtypes infected trachea, bronchi, and lungs of macaques and marine mammals with variable peak titers and kinetics. We adapted the approach for SARS-CoV-2 and observed that the infection kinetics in inoculated rhesus macaque explants parallel observations from ex vivo human lungs. This ex vivo model can define infection dynamics for 2 respiratory viruses of significant public health importance and use of explants from animals euthanized for other reasons reduces use of animals in research.

at 37°C with 5% CO2, 3 ml viral-growth-medium containing 1 ug/ml N-p-tosyl-L-196 phenylalaninechloromethyl ketone-treated (TPCK) and 0.5% agarose was added to each well. Infection kinetics for the 6 IAV strains and 1 SARS-CoV-2 strain were assessed in MDCK and 220

Vero E6 cells, respectively. Both cell types were grown at 37°C with 5% CO2 to 6 x 10 5 221 cells/well in 24-well plates and inoculated in triplicate with 6 x 10 3 PFU virus of IAV, 222 representing a multiplicity of infection (MOI) of 0.01, or 6 x 10 3 , 6 x 10 4 , or 6 x 10 5 PFU of 223 SARS-CoV-2, representing MOIs of 0.01, 0.1 or 1, respectively. After 1 hour incubation, each 224 well was washed with 1 ml of DPBS 3 times to remove unbound virus. Next, viral growth 225 medium supplemented with 1 ug/ml TPCK trypsin for IAV or Vero-growth medium for SARS-226

CoV-2 was added to each well. The supernatant was sampled at 1, 24, 48, and 72 hours post-227 inoculation and then diluted and frozen at -80°C in virus growth medium. Viral titers were 228 assessed by plaque assay. 229 230

To evaluate IAV or SARS-Cov-2 infection kinetics ex vivo, trachea, bronchi, and lung explants 233 were inoculated in triplicate (when sufficient tissue was available) with 1 x 10 4 PFU of one of 234 each of the 6 IAV strains or 1 SARS-CoV-2 strain in 10 ul viral growth medium onto the 235 epithelial surface of each section for rhesus macaques. The inoculum volume for marine 236 mammals was adjusted to 20 ul at a dose of 2 x 10 4 PFU of each IAV strain. Viral growth 237 medium was used in the mock-infected control explants. Inoculated explants were sampled at 1 238 hour post infection (hpi) and every 24 hours up to 72 hpi (or as indicated in graphs) for viral 239 quantification and histology. For viral quantification, each infected explant ( for both IAV and 240 SARS-CoV-2 ) was directly immersed in 0.5 ml RPMI-growth-medium in a 2 ml centrifuge tube 241 with a 5 mm glass bead and homogenized in a Mixer Mill MM300 (Retsch, Leeds, UK) at 30 242 hertz for 4 minutes at 22°C followed by centrifugation at 16,000 g for 4 minutes and storage at -243 80°C. Titers of the released progeny virus from explants were determined by plaque assay. 244

Titers are reported as the geometric mean of triplicate explants at each time point. 245

To determine whether IAV detected after inoculation was due to productive virus infection in 247 respiratory tissues, we performed viral stability assays in the absence of tissue sections. 248

Medium containing 1 X 10 4 PFU/ml of each of the 6 IAV strains was added to 24-well tissue 249 culture plates and supernatant was collected at 0, 24 and 48 hpi for the determination of viral 250 titers by plaque assay. As a second step, the stability assays were also performed using non-251 target tissues (liver and kidney) to confirm that the viral titers detected in respiratory tissues 252 reflect productive infection in target cells. Liver and kidney explants were inoculated with 1 x 253 10 4 PFU of each of the 6 IAV strains or SARS-CoV-2 in 10 ul RPMI growth medium and 254 assayed by the same methods used for respiratory tract tissues. 255

Tracheal, bronchial, and lung explants from a subset of IAV-inoculated animals (M11, M13, SL08, and 257 SL12) were fixed in 10% buffered formalin and embedded in paraffin. These animals were selected 258 since they showed higher IAV titers than others. Antigen retrieval was performed on 5 um sections via 259 incubation in AR10 (Biogenex) in a digital decloaking chamber (Biocare Medical) for 2 minutes at 260 125°C, followed by cooling to 90°C for 10 minutes, rinsing with water, and a final Tris-buffered saline 261 with 0.05% Tween 20 rinse. Tissue sections were exposed to the primary rabbit anti-influenza A virus 262 nucleoprotein antibody (LSBio), at a ratio of 1:250 with antibody diluent (Dako). Primary antibody was 263 replaced by normal rabbit IgG (Invitrogen) to serve as a negative isotype control. Tris-buffered saline 264 with 0.05% Tween 20 was used for all washes. Nonspecific binding sites were blocked with 5% 265 bovine serum albumin (Jackson ImmunoResearch). Binding of the primary antibody was detected 266 using Envision rabbit polymer with AEC as the chromogen (Dako). Each tissue section was evaluated 267 independently by two pathologists. Sections from slides were visualized with a Zeiss Imager Z1 (Carl 268 Zeiss). Digital images were captured and analyzed using Openlab software (Improvisation). were used to compare changes in mean log10 viral titers from 1 to 24, 48, and 72 hpi across 315 IAV strains, tissues within species, and by IAV strain and tissue pairs between species. 316 317 Results 318

We first compared relative infection kinetics for the 6 IAV strains used here ( Table 1) . The 320 strains used were selected since they represent common IAV subtypes, some of which infect 321 humans. Strains were isolated from mallard ducks (m, N=4), an elephant seal (ES, N=1), or a 322 harbor seal (HS, N=1), and they share similar passage histories in embryonated chicken eggs 323 and MDCK cells. Our rationale for using IAV strains of avian origin in addition to strains from 324 marine mammals is that waterbirds serve as primary reservoirs of IAV and they share shore 325 environments with marine mammals. The ES H1N1 strain is a human pandemic IAV. 326 327

Infection kinetics for each of the 6 IAV strains were assessed by inoculation into MDCK cells in 329 triplicate at a MOI of 0.01 (Figure 1) . The H3N8 strain isolated from a harbor seal (HS/H3N8), 330 exhibited the slowest and lowest growth kinetics, peaking at 10 5 PFU/ml 48 hpi. The H1N1 331 strains showed the fastest and highest growth kinetics, peaking at >10 7 PFU/ml by 24 hpi. The 332 viral infection kinetics of the other 3 strains tested, all of which were isolated from mallard 333 ducks, were intermediate between HS/H3N8 and the 2 H1N1 strains. Titers for all strains were 334 significantly higher than those for HS/H3N8 at one or more time points between 24-72 hpi (two 335 way ANOVA). Given these data show that in vitro infection kinetics in an immortalized cell line 336 are different for the 6 IAV strains used in this study, we sought to determine whether the growth 337 patterns of these strains also differed in explant tissues from the 3 animal species. 338 339 Table 2) with 6 virus strains. Five of the macaques were females and five were males, they 363 ranged from 1 to 16 years of age, and most were euthanized due to injuries sustained due to 364 non-respiratory conditions including trauma or chronic diarrhea. Four of the IAV strains were 365 isolated from mallard ducks and two were from marine mammals. We focused on 0 to 72 hpi 366 since increases in IAV titers were observed over that period in the preliminary experiment 367 Table 2 ). The causes of death varied and 386 were sometimes ascribed to an infectious or toxic etiology, but were not typically due to 387 respiratory disease. All California sea lions used in this study had a mild burden of a lung 388 worm, Parafilaroides decorus, which is found as a normal occurrence in healthy animals (36). 389

As in rhesus macaques, IAV infection kinetics for most strains increased in California sea lions 390 from 0 to 72 hpi in all 3 tissues and reached highest levels at 72 hpi for most strains ( Figure  391 3E-G). Similar to rhesus macaques, the mean area under the curve (AUC) was significantly 392 higher for H3N8 and H7N5 strains compared to H1N1 and H5N2 strains in trachea and bronchi 393 while the AUC in lung explants from sea lions was only higher for H7N5 (Figure 3H) Table 2 ). Infection kinetics in bronchi and trachea 427 from rhesus macaques were significantly higher than in the lung over all 24 hour windows from 428 1 to 72 hpi. In California sea lions, infection kinetics in bronchi and trachea were significantly 429 higher than in the lung at 24 hpi, while infection kinetics in bronchi were significantly higher than 430 in the trachea and lung at 48 and 72 hpi. Together, these data support tissue-specific IAV 431 infectivity, where bronchi and trachea explants from both species support production of higher 432 IAV titers than lungs. 433 434 IAV Kinetics by Species: To evaluate whether species associates with infection kinetics for the 435 6 IAV strains, we compared changes in mean log10 titer between rhesus macaque and 436

California sea lion explants (Supplemental Table 3 

IAV genomes in inoculated explants from 2 rhesus macaques, 3 California sea lions, and 1 Northern 469 elephant seal were compared to sequences in strains used as inocula (Supplemental Table 5 ). 470

Sequence comparisons showed that all genomes from rhesus macaque explants were 100% identical 471 at the consensus level (mutations occurring on 50% or more of viral RNAs) to their corresponding 472 inoculum (data not shown). Six nonsynonymous nucleotide substitutions in the HA, NA, and PA genes 473 were detected in California sea lion and Northern elephant seal explants inoculated with different IAV 474 subtypes (Supplemental Table 6 

Using African green monkey kidney (Vero) cells, we first characterized infection kinetics (Figure 6A (Figure 6B) . Labeling patterns were similar to those previously described with 492 SARS-CoV-2 (37), and manifest as punctate reactivity within the cytoplasm and an eccentric halo 493 around the nucleus, which, based on the known replication cycle and assembly of coronaviruses, 494 corresponds to association with endoplasmic reticulum, which is contiguous with the nuclear 495 envelope. We expanded the explant system with a similar approach as for IAV ( Figure 6C) to 496 characterize SARS-CoV-2 susceptibility and infection dynamics in respiratory tract explants from 2 497 rhesus macaques by inoculating 1X10 4 PFU of SARS-CoV-2 into trachea, lung, kidney, and liver, 498

where the latter 2 tissues were included as non-target controls. Similar to IAV, SARS-CoV-2 infected 499 the trachea of both macaques and the lung of a 2.3 year-old female (M31), but no infectious virus was 500 detected in the lung of a 4 month-old female macaque 24 hpi (M32) (Figure 6D) . SARS-CoV-2 501 infected the kidney but not the liver from both animals. Immunofluorescence of infected lung explants 502 48 hpi using an antibody directed against SARS-CoV-2 mirrored infectious virus detected by titrations. Ex vivo respiratory tract models have been used for studying respiratory pathogens of humans, 519 swine, bovines, canines, and equines (23, 25-28, 38-40). Ex vivo cultures of respiratory 520 tissues provide a close resemblance to the respiratory tract in vivo by: 1) shared polarity, where 521 the basolateral surface is exposed to culture medium and the apical cell surface is exposed to 522 air, 2) shared cell positioning in situ which could maintain virus receptor distribution, 3) 523 possession of multiple cell types and states of differentiation, 4) maintenance of the three 524 dimensional integrity and architecture of a tissue, unlike cell monocultures, and 5) ciliary activity 525 to maintain mucociliary clearance. Given these similarities to living IAV hosts, explants are 526 valuable tools for assessing host susceptibility, infection kinetics, and pathogenesis of 527 respiratory pathogens. The ex vivo systems also better assess infectivity compared to cell 528 monoculture binding assays that only measure virus-receptor affinity (25, 27). In addition, 529 tissues collected from a single animal can be divided into pieces and used to compare relative 530 infectivity of different viral strains while holding the host constant. Last, use of explants from 531 animals euthanized for other reasons reduced the number of animals used in research, 532 following the principles of reduction, replacement, and refinement. 533

Limitations of the ex vivo approach include restricted availability of tissues, short periods of 534 viability, and inter-animal variability in IAV susceptibility. The absence of a blood supply also 535 constitutes a weakness of the ex vivo respiratory explant system since recruitment of immune 536 cells to the infection site cannot occur. However, such a pitfall might be co-opted in future 537 studies to understand the effects of innate and intrinsic immunity without immune cell influx. The infection kinetics of H3N8 and H7N5 strains in rhesus macaque and California sea lion 546 respiratory tract explant tissues were superior to H1N1 and H5N2 strains, although all share similar 547 passage histories. A similar pattern of differential strain infectivity was observed in swine, where 548 human H3N2 infected explants more efficiently than H1N1 (41), and in humans, where H7N9 549 achieved higher titers than high pathogenic H5N1 and H5N6 (27). In spite of the different infection 550 kinetics across strains, the 6 strains used here, representing 4 IAV subtypes, productively infected at 551 least one explant type for both species. These data suggest that any of these subtypes could also 552 infect marine mammals in the wild, consistent with serologic data showing exposure to many subtypes 553 (13-16, 18, 19) . 554

The observation that SARS-CoV-2 infects ex vivo rhesus macaque explants parallels findings from ex 556 vivo lungs from human donors whose lungs were removed due to tumors or from patients undergoing 557 elective surgery (28, 42). Infection kinetics increased from 2 to 48 hpi in explants and increases in 558 x 10 4 PFU of each of the 6 IAV strains over a 72 hour period. The kinetics of viral infection were determined by plaque assays of homogenized explants, where each square represents the titer from 10 1 (blue) to 10 6 (yellow) in PFU/explant. The limit of detection was 50 PFU/explant. Each explant was titrated once at 2-3 dilutions. Strain names refer to the original source of the virus isolate followed by the hemagglutinin and neuraminidase subtype (Table 1) . HS is harbor seal. m is mallard. ES is elephant seal. Boxes with 'X' indicate the sample was not available for titration. designated MOIs. The geometric mean virus titer from triplicate wells at each time point is plotted as PFU per milliliter ± geometric standard deviation. The dotted line represents the limit of detection (LOD) of 80 PFU/ml. a denotes that the mean titer for the MOI 1 wells was significantly different from the MOI 0.1 and 0.01 groups (p<0.01), b shows that the mean titer for the MOI 0.01 wells was significantly different from the MOI 0.1 and 1 groups (p<0.01). Table 2 ) inoculated with 1X10 4 PFU of 6 viral strains. Viral titers are represented as the geometric mean and geometric standard deviation. Three explants at each time point were titrated independently and the mean of the triplicates is represented by the middle horizontal line. Asterisks show p values (two-way ANOVA with Dunnett's multiple comparisons) comparing titers at 24, 48 or 72 hpi to 1 hpi, respectively. **p £ 0.005, ***p < 0.001, and ****p < 0.0001. The dashed line indicates limit of detection, 50 PFU/explant. Strain names refer to the original source of the virus isolate followed by the hemagglutinin and neuraminidase subtype. HS is harbor seal. m is mallard. ES is elephant seal. Figure S2 . Influenza A virus infection kinetics from 1 to 96 hpi in respiratory tract explants from an adult female California sea lion (SL12 in Table 2 ) inoculated with 2X10 4 PFU of 6 IAV strains. Viral titers are represented as the geometric mean and geometric standard deviation. Three explants at each time point were titrated independently and the mean of the triplicates is represented by the middle horizontal line. Asterisks show p values (two-way ANOVA with Dunnett's multiple comparisons) comparing titers at 24, 48, 72 or 96 hpi to 1 hpi, respectively. **p < 0.005, ***p < 0.001, and ****p < 0.0001. The dashed line indicates limit of detection, 50 PFU/explant. Strain names refer to the original source of the virus isolate followed by the hemagglutinin and neuraminidase subtype. HS is harbor seal. m is mallard. ES is elephant seal.

Means for the same time frame followed by a common letter are not significantly different by the Games-Howell test at the 5% level of significance. Values in parentheses show standard deviations. The symbols indicate that the mean change in titer differs significantly for at least one strain according to Welch's ANOVA at 5% level of significance for: *1 vs 24 hpi F=15.417, df=(5,91.649), p-value=5.55e-11 for rhesus macaques and F=4.666, df=(5,189.21), p-value=4.85e-04 for California sea lions, the † denotes 1 vs 48 hpi (F=25.823, df=(5,91.569), p-value=3.59e-16) for rhesus macaques and (F=5.784, df=(5,182.59), p-value=5.55e-05) for California sea lions, and the ‡ denotes 72 hpi (F=23.351, df=(5,91.826), p-value=4.58e-15) for rhesus macaques and (F=6.636, df=(5,189.35), p-value=1.02e-05) for California sea lions. Strain names refer to the original source of the virus isolate followed by the hemagglutinin and neuraminidase subtype. HS is harbor seal. m is mallard. ES is elephant seal. 

Up to new tricks -a review of cross-species transmission of 597 influenza A viruses

Influenza virus evolution, host adaptation, and pandemic 599 formation

Pandemic H1N1 Influenza Isolated from Free-Ranging 602

Northern Elephant Seals in 2010 off the Central California Coast

Respiratory transmission of an avian H3N8 influenza virus isolated from a harbour seal

Adaptive pathways of zoonotic influenza 607 viruses: From exposure to establishment in humans

The avian and mammalian host range of highly pathogenic avian 609 H5N1 influenza

Weighing serological evidence of 611 human exposure to animal influenza viruses − A literature review

Inventory of 614 molecular markers affecting biological characteristics of avian influenza A viruses

Isolation of an influenza A virus from seals

Characterization of an influenza A virus from seals

Mass mortality of harbor seals: 622 Pneumonia associated with influenza A virus

Antibodies to human-related H3 influenza A virus in Baikal seals (Phoca sibirica) and 625 ringed seals (Phoca hispida) in Russia

Influenza virus infection of 627 marine mammals

Prevalence of influenza A virus in live-captured North Atlantic gray seals: A 631 possible wild reservoir

Serological investigation of 633 virus infections in harp seals (Phoca groenlandica) and hooded seals (Cystophora cristata)

Serologic evidence of influenza A infection in marine 636 mammals of Arctic Canada

Surveillance for zoonotic and selected 639 pathogens in harbor seals Phoca vitulina from central California

Serologic evidence of influenza virus 642 infection in a ringed seal (Phoca hispida) from Alaska

Detection of H3N8 influenza A 645 virus with multiple mammalian-adaptive mutations in a rescued Grey seal (Halichoerus grypus) 646 pup

Serologic detection of subtype-specific antibodies to influenza A viruses in southern sea 649 otters (Enhydra lutris nereis)

Surveillance for highly pathogenic influenza A viruses in California during

provides insights into viral evolutionary pathways and the spatiotemporal extent of viruses in 654 the Pacific Americas Flyway

An ex 656 vivo swine tracheal organ culture for the study of influenza infection. Influenza Other Respi 657 Viruses

The infectivity of 659 pandemic 2009 H1N1 and avian influenza viruses for pigs: An assessment by ex vivo 660 respiratory tract organ culture

Use of ex vivo and in vitro cultures 662 of the human respiratory tract to study the tropism and host responses of highly pathogenic 663 avian influenza A (H5N1) and other influenza viruses

A Novel Lung Explant Model for the Ex Vivo Study of Efficacy and Mechanisms of Anti-667

Tropism, replication competence, and innate immune responses of influenza virus: an 670 analysis of human airway organoids and ex-vivo bronchus cultures

Tropism, replication 674 competence, and innate immune responses of the coronavirus SARS-CoV-2 in human 675 respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures

Respiratory disease in rhesus macaques 680 inoculated with SARS-CoV-2

SARS-CoV-2 infection protects against 688 rechallenge in rhesus macaques

Primary exposure to SARS-CoV-2 protects against reinfection in rhesus 692 macaques

Engineering a fidelity-variant live-attenuated vaccine for chikungunya 694 virus. 2020. npj Vaccines 1-14

Origins of the 2009 H1N1 influenza pandemic in swine in Mexico

Avian Influenza Viruses in Wild Birds: Virus Evolution in a 703

Core Team. 2020. R: A language and environment for statistical computing. R Foundation for

Statistical Computing

A Decade of Live California Sea Lion (Zalophus 707 californianus) Strandings Along the Central California Coast: Causes and Trends

replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

In vitro culture of equine respiratory mucosa explants

Quantification of mRNA 717 encoding cytokines and chemokines and assessment of ciliary function in canine tracheal 718 epithelium during infection with canine respiratory coronavirus (CRCoV)

Critical 721 assessment of an in vitro bovine respiratory organ culture system: A model of bovine 722 herpesvirus-1 infection

Replication of avian, human 724 and swine influenza viruses in porcine respiratory explants and association with sialic acid 725 distribution

Comparative replication and immune activation profiles of SARS-CoV-2 and 729

SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of

Pandemic H1N1 Influenza Isolated from Free-Ranging Northern Elephant Seals in 2010 off the Central California Coast

Respiratory transmission of an avian H3N8 influenza virus isolated from a harbour seal

Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California

Trachea from California sea lion SL08 24 hours post inoculation with av/H3N8. Positive respiratory epithelial cells exhibit strong nuclear immunoreactivity (red-brown nuclear staining; arrows). Positive staining is primarily localized to apical epithelial cells, with relative sparing of basal cells. IHC stain used an antibody against influenza A virus nucleoprotein. Bar=50um.